Cite
HARVARD Citation
Rugo, H. et al. (n.d.). 339PManagement of abemaciclib associated adverse events in patients with hormone receptor positive (HR+), HER2- advanced breast cancer: Analysis of the MONARCH trials. Annals of oncology. p. . [Online].